Call for Abstract
25th World Biotechnology Congress, will be organized around the theme “Innovative Risings in Biotechnology and Novel Drug Discovery modalities to combat the pandemic: Covid-19”
World Biotechnology 2020 is comprised of keynote and speakers sessions on latest cutting edge research designed to offer comprehensive global discussions that address current issues in World Biotechnology 2020
Submit your abstract to any of the mentioned tracks.
Register now for the conference by choosing an appropriate package suitable to you.
Biotechnology is the wide zone of science including living systems and organisms to create or make items, or "any innovative application that utilizes natural systems, living beings, or subordinates thereof, to make or alter items or procedures for explicit use". Contingent upon the devices and applications, it frequently covers with the (related) fields of molecular biology, bio-engineering, biomedical engineering, bio manufacturing, molecular engineering, etc
Nano biotechnology refers to the intersection of engineering science and biology. Only if the topic is one that has solely emerged terribly recently, Bio engineering science and Nano biotechnology function blanket terms for numerous connected technologies. The foremost necessary objectives that square measure often found in Nano biology involve applying Nano tools to relevant medical/biological issues and refinement these applications. The imaging of native biomolecules, biological membranes, and tissues is additionally a significant topic for the Nano-biology researchers. Alternative topics regarding Nano biology embrace the utilization of cantilever array sensors and therefore the application of Nano-photonics for manipulating molecular processes in living cells. The global nanomedical market was valued at $134.4 billion in 2016. This market is projected to grow at a compound annual growth rate (CAGR) of 14.0% from 2017-2022, and should reach $293.1 billion by 2022 from $151.9 billion in 2017
Algal biotechnology may be a technology developed using algae. Biotechnology is to more the understanding of the ecology of microalgae. This can assist with the event of commercial-scale small protoctist culturing techniques for the assembly of bioactive compounds, cultivation feed, fine chemicals, and renewable fuels. in addition, environmental applications like CO2 bioremediation, management of excessive protoctist growth and development of management ways for installation managers square measure investigated. Trangenesis in protoctist may be a advanced and invasive technology. Selectable marker genes, promoters, communicator genes, transformation techniques, and different genetic tools and ways square measure already accessible for numerous species and presently ~25 species square measure accessible to genetic transformation. Fortuitously, large-scale sequencing comes also are planned, ongoing, or completed for many of those species. A $2.4M purchase order for Algae.Tec algae production technology as a follow-up to an initial investment of A$1.5M by Reliance, with additional investments of AU$1.2 million over the next 2 years.
Biomedical Engineering has only recently emerged as its own study, as compared to many other engineering fields. Such an evolution is common as a new field transitions from being an interdisciplinary specialization among already-established fields, to being considered a field in itself. Much of the work in biomedical engineering consists of research and development, spanning a broad array of subfields.
Pharmaceutical Biotechnology is widely spread, ranging from many ethical issues to changes in healthcare practices and a significant contribution to the development of national economy. World Biotechnology will focus on Biopharmaceuticals Discovery, Biopharmaceutical Regulations and Validations, Biologics and Biosimilars and Clinical Research/Clinical trials.
Genetics and Molecular biotechnology is the use of laboratory techniques to study and modify nucleic acids and proteins for applications in areas such as human and animal health, agriculture, and the environment. Molecular biotechnology, microbiology, immunology, and cell biology. It is an exciting field fueled by the ability to transfer genetic information between organisms with the goal of understanding important biological processes or creating a useful product. The tools of molecular biotechnology can be applied to develop and improve drugs, vaccines, therapies, and diagnostic tests that will improve human and animal health. Molecular biotechnology has applications in plant and animal agriculture, aquaculture, chemical and textile manufacturing, forestry, and food processing.
Biotechnology is applied and wont to study the natural atmosphere. Environmental biotechnology might additionally imply that one try and harness process for industrial uses and exploitation. Environmental biotechnology as "the development, use and regulation of biological systems for correction of contaminated environments and for environment-friendly processes (green producing technologies and property development)”. Environmental biotechnology will merely be represented as "the best use of nature, within the style of plants, animals, bacteria, fungi and protoctist, to supply renewable energy, food and nutrients in an exceedingly synergistic integrated cycle of profit creating methods wherever the waste of every process becomes the feedstock for one more process". U.S. sales of environmental biotechnology products was valued at $241.2 million in 2012. This is expected to increase at a total compound annual growth rate (CAGR) of 7.9%, with 2013 sales of $261.9 million, rising to $382.3 million in 2018
Cell and Molecular biotechnology is that the use of laboratory techniques to check and modify nucleic acids and proteins for applications in areas like human and animal health, agriculture, and therefore the atmosphere. Molecular biotechnology results from the convergence of the many areas of analysis, like biology, organic chemistry, immunology, genetics, and cell biology. It's associate degree exciting field fueled by the power to transfer genetic info between organisms with the goal of understanding vital biological processes or making a helpful product. The tools of molecular biotechnology are often applied to develop and improve medication, vaccines, therapies, and diagnostic tests that may improve human and animal health. Molecular biotechnology has applications in plant and animal agriculture, cultivation, chemical and textile producing, forestry, and food process. The global digital molecular biotechnology market totaled $425.0 million in 2017 and is estimated to reach $746.0 million by 2022, growing at a compound annual growth rate (CAGR) of 11.9% for the period of 2017-2022.
Agriculture Biotechnology is an area of agricultural science involving the use of scientific tools and techniques, including genetic engineering is one aspect of agricultural biotechnology which has been greatly developed upon in recent times. Desired trait is exported from a particular species of Crop to an entirely different species. These transgene crops possess desirable characteristics in terms of flavour, colour of flowers, growth rate, size of harvested products and resistance to diseases and pests.
Genetic engineering, also called genetic modification or genetic manipulation, is the direct manipulation of an organism's genes using biotechnology. It is a set of technologiesused to change the genetic makeup of cells, including the transfer of genes within and across species boundaries to produce improved or novel organisms. New DNA is obtained by either isolating and copying the genetic material of interest using recombinant DNA methods or by artificially synthesising the DNA. A construct is usually created and used to insert this DNA into the host organism. The global market for genetic modification therapies should grow from $2.3 billion in 2018 to reach $17.4 billion by 2023, growing at a compound annual growth rate (CAGR) of 49.9% during the forecast period of 2018-2023.
Animal biotechnology is a immense field of study and includes the subsequent topics: use of animals in analysis clones transgenic animals and gene pharming animal health. Animals play a significant role in primary analysis. The utilization of animal models permits a lot of fast assessment of the consequences of recent medical treatments and alternative merchandise. Testing on live animal models needs that 2 or a lot of species be used as a result of completely different effects square measure discovered in several animals. If issues are detected within the animal tests, human subjects are never recruited for trials. The animals used most frequently square measure pure-bred mice and rats, however alternative species are used. Another extraordinarily valuable analysis animal is that the zebra fish, a hardy fish tank fish. Dogs are used for the study of cancer, heart disease and lung disorders. HIV and AIDS analysis is conducted on monkeys and chimpanzees. The contribution of this sector in national economy was approximately 3.9% in 2011-12. India ranks first in the world in milk production with an estimated production of 132.4 million tonnes in 2012-13. India is also third largest egg-producer in the world, over 69.7 billion eggs were produced in 2012-13.
Systems and Synthetic Biotechnology could be a comparatively new field in medical specialty analysis. It focuses on engineering new or changed communication proteins to form desired communication pathways within the cell. Thanks to very good regulation, many cells, like photoreceptors and different neurons in vertebrates, will live for many years. Thanks to elucidation of the intricacies of cellular restrictive mechanisms we are able to currently play evolution on our time scale: re-design proteins and communication pathways to attain our ends. Systems and synthetic Biology could be a novel field that finds its origin at the intersection of biology and engineering. It's a multidisciplinary effort created by scientists to grasp the functioning of biological organisms, cells & genes and implementation of artificial genetic processes to convey specific characteristics to an organism. It will even be wont to develop a totally new biological system. The global market for synthetic and natural waxes will grow from $1.3 billion in 2017 to $1.9 billion by 2022, at a compound annual growth rate (CAGR) of 8.5% from 2017 to 2022.
Biomaterials is a substance that has been designed to act with biological systems for a medical purpose - either a therapeutic (treat, augment, repair or replace a tissue perform of the body) or a diagnostic one. It’s experienced steady and robust growth over its history, with several firms finance massive amounts of cash into the event of latest product. Biomaterials also are used on a daily basis in dental applications, surgery, and drug delivery.
Genome piece of writing and also the utilization of CRISPR based technologies are expected to revolutionize the assembly of succeeding generation of bio product. DCB12 will concentrate on the foremost recent developments among the employment of CRISPR/Cas9 and different CRISPR based technologies in relevance the event and production of biopharmaceuticals, biochemical, agricultural crops and travel applications. The global market for genetic modification therapies should grow from $2.3 billion in 2018 to reach $17.4 billion by 2023, growing at a compound annual growth rate (CAGR) of 49.9% during the forecast period of 2018-2023.
Bioprocess Engineering combines biotechnology and engineering for the producing of materials from renewable feedstock. This field includes basic bio molecular analysis on proteins, enzymes and microbes, in addition as work on biosensors, bio separations and bioreactors. Applications embrace food process and preservation; pharmaceutical, nutraceutical and sweetener production; air and waste material treatment; bio-based structural motifs for above molecular architectures; microfluidics for bioreactors and DNA chips; bioenergy; and applications within the pulp and paper business. There square measure natural links to medicine applications, like drug metabolism, tissue engineering and bio-based therapeutic treatments. The alternative U.S chemical end-use product market is expected to increase from $149.9 billion in 2016 to an estimated $345.6 billion by 2021. It should reach $884.1 billion by 2026, with a compound annual growth rate (CAGR) of 19.4% for the period of 2016-2026.